Parkinson's Disease: From Pathogenesis to Pharmacogenomics
about
Chinese Medicine: A Hope for Neurodegenerative Diseases?Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.Modulation of Nrf2 by Olive Oil and Wine Polyphenols and Neuroprotection.Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.The future of pharmacogenetics in Parkinson's disease treatment.Oleic Derivatives of Dopamine and Respiration.Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects.Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system.Neuroprotective Effects of Proanthocyanidins, Natural Flavonoids Derived From Plants, on Rotenone-Induced Oxidative Stress and Apoptotic Cell Death in Human Neuroblastoma SH-SY5Y Cells.Clinical Heterogeneity Among Variants in Parkinson's Disease: A Meta-AnalysisSystemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugsApplication of Precision Medicine in Neurodegenerative Diseases
P2860
Q38663621-42565793-3207-4996-B928-62DF651892B7Q39400501-6D950749-7AAB-4D55-9592-F6B5579C7542Q42379274-C95D9B7F-92FD-4692-8F3F-26C0971F54B5Q46311037-0CB5EFF0-8535-4AC0-AE0A-FC45E85D2144Q47140885-DACCD8C5-06F4-4355-B82E-6C9DED908301Q47563960-FE3549B0-7B4B-4B7D-818E-4B6D023DE165Q47808802-383A2FBB-6F7F-4B7C-9EA8-D887C6D7BFA2Q47841860-9EFDCD58-EAFE-4D6D-8158-6B4330B74549Q49797218-B113011B-0A40-40D4-9411-D17E43871F33Q49843356-BBA82033-C7E4-40C7-B568-6D51CA537432Q55044611-8A3A63B8-716B-4621-8ACF-0A7E58690A86Q55265085-15EDBDB8-0BF3-4334-81AD-58E703F6E825Q57072461-2347E2C9-D4D6-44D6-A62F-8A365C631056Q58586423-9F5BB5A1-B20D-4724-BB9D-DB476B23A9F5Q58712882-D1944963-E92B-4E77-A19D-0CDB9AD2189E
P2860
Parkinson's Disease: From Pathogenesis to Pharmacogenomics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Parkinson's Disease: From Pathogenesis to Pharmacogenomics
@en
Parkinson's Disease: From Pathogenesis to Pharmacogenomics.
@nl
type
label
Parkinson's Disease: From Pathogenesis to Pharmacogenomics
@en
Parkinson's Disease: From Pathogenesis to Pharmacogenomics.
@nl
prefLabel
Parkinson's Disease: From Pathogenesis to Pharmacogenomics
@en
Parkinson's Disease: From Pathogenesis to Pharmacogenomics.
@nl
P2860
P921
P356
P1476
Parkinson's Disease: From Pathogenesis to Pharmacogenomics
@en
P2860
P356
10.3390/IJMS18030551
P407
P5008
P577
2017-03-04T00:00:00Z